Please wait while the formulary information is being retrieved.
SYNVISC (HYLAN G-F 20)
- Osteoarthritis of the knee
16 mg/2 mL intra-articular syringe
- Inject 2 milliliters (16 mg) by intra-articular route once weekly into the affected knee
Osteoarthritis of the knee
- Inject 2 milliliters (16 mg) by intra-articular route once weekly into right knee
- Inject 2 milliliters (16 mg) by intra-articular route once weekly into left knee
- Inject 2 milliliters (16 mg) by intra-articular route once weekly into the affected knee
- Inject 2 milliliters (16 mg) by intra-articular route once weekly into each knee
- None
Contraindicated
- None
Severe
Moderate
- None
- Osteomyelitis
Contraindicated
- None
Severe
Moderate
- None
SYNVISC (HYLAN G-F 20)
- Osteoarthritis of the knee
- None
- Injection site sequelae
- Knee inflammation
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Dyspnea
- Infectious disorder of joint
- Thrombocytopenic disorder
- Urticaria
Less Severe
- Chills
- Cramps in legs
- Dizziness
- Fatigue
- Fever
- Flushing
- Headache disorder
- Lip hypertrophy
- Malaise
- Myalgias
- Nausea
- Pain
- Paresthesia
- Peripheral edema
- Pruritus of skin
- Skin rash
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Hylan G-F 20
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Hylan G-f 20
- Severity Level:
2
- Additional Notes: Insufficient data available.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Hylan G-f 20
Insufficient data available.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Osteoarthritis of the knee | |
| M17 | Osteoarthritis of knee |
| M17.0 | Bilateral primary osteoarthritis of knee |
| M17.1 | Unilateral primary osteoarthritis of knee |
| M17.10 | Unilateral primary osteoarthritis, unspecified knee |
| M17.11 | Unilateral primary osteoarthritis, right knee |
| M17.12 | Unilateral primary osteoarthritis, left knee |
| M17.2 | Bilateral post-traumatic osteoarthritis of knee |
| M17.3 | Unilateral post-traumatic osteoarthritis of knee |
| M17.30 | Unilateral post-traumatic osteoarthritis, unspecified knee |
| M17.31 | Unilateral post-traumatic osteoarthritis, right knee |
| M17.32 | Unilateral post-traumatic osteoarthritis, left knee |
| M17.4 | Other bilateral secondary osteoarthritis of knee |
| M17.5 | Other unilateral secondary osteoarthritis of knee |
| M17.9 | Osteoarthritis of knee, unspecified |
| 0-9 | A-Z |
|---|---|
| M17 | Osteoarthritis of knee |
| M17.0 | Bilateral primary osteoarthritis of knee |
| M17.1 | Unilateral primary osteoarthritis of knee |
| M17.10 | Unilateral primary osteoarthritis, unspecified knee |
| M17.11 | Unilateral primary osteoarthritis, right knee |
| M17.12 | Unilateral primary osteoarthritis, left knee |
| M17.2 | Bilateral post-traumatic osteoarthritis of knee |
| M17.3 | Unilateral post-traumatic osteoarthritis of knee |
| M17.30 | Unilateral post-traumatic osteoarthritis, unspecified knee |
| M17.31 | Unilateral post-traumatic osteoarthritis, right knee |
| M17.32 | Unilateral post-traumatic osteoarthritis, left knee |
| M17.4 | Other bilateral secondary osteoarthritis of knee |
| M17.5 | Other unilateral secondary osteoarthritis of knee |
| M17.9 | Osteoarthritis of knee, unspecified |
Formulary Reference Tool